title: From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection.
abstract: Plasma levels of the inflammatory biomarker high-sensitivity C-reactive protein (hsCRP) predict vascular risk with an effect estimate as large as that of total or high-density lipoprotein cholesterol. Further, randomized trial data addressing hsCRP have been central to understanding the anti-inflammatory effects of statin therapy and have consistently demonstrated on-treatment hsCRP levels to be as powerful a predictor of residual cardiovascular risk as on-treatment levels of low-density lipoprotein cholesterol. Yet, although hsCRP is clinically useful as a biomarker for risk prediction, most mechanistic studies suggest that CRP itself is unlikely to be a target for intervention. Moving upstream in the inflammatory cascade from CRP to interleukin (IL)-6 to IL-1 provides novel therapeutic opportunities for atheroprotection that focus on the central IL-6 signaling system and ultimately on inhibition of the IL-1β-producing NOD-like receptor family pyrin domain containing 3 inflammasome. Cholesterol crystals, neutrophil extracellular traps, atheroprone flow, and local tissue hypoxia activate the NOD-like receptor family pyrin domain containing 3 inflammasome. As such, a unifying concept of hsCRP as a downstream surrogate biomarker for upstream IL-1β activity has emerged. From a therapeutic perspective, small ischemia studies show reductions in acute-phase hsCRP production with the IL-1 receptor antagonist anakinra and the IL-6 receptor blocker tocilizumab. A phase IIb study conducted among diabetic patients at high vascular risk indicates that canakinumab, a human monoclonal antibody that targets IL-1β, markedly reduces plasma levels of IL-6, hsCRP, and fibrinogen with little change in atherogenic lipids. Canakinumab in now being tested as a method to prevent recurrent cardiovascular events in a randomized trial of 10 065 post-myocardial infarction patients with elevated hsCRP that is fully enrolled and due to complete in 2017. Clinical trials using alternative anti-inflammatory agents active against the CRP/IL-6/IL-1 axis, including low-dose methotrexate and colchicine, are being explored. If successful, these trials will close the loop on the inflammatory hypothesis of atherosclerosis and serve as examples of how fundamental biologic principles can be translated into personalized medical practice.
authors.affiliation: From the Center for Cardiovascular Disease Prevention, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. pridker@partners.org.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Ridker
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000378:metabolism; D050197:Atherosclerosis / Q000188:drug therapy* / Q000378:metabolism*; D015415:Biomarkers / Q000378:metabolism; D002097:C-Reactive Protein / Q000037:antagonists & inhibitors / Q000378:metabolism*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000378:metabolism; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015850:Interleukin-6 / Q000378:metabolism*; D000093242:Interleukin-6 Inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D002097:C-Reactive Protein; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007375:Interleukin-1; D015850:Interleukin-6; D000093242:Interleukin-6 Inhibitors; C508600:IL6 protein, human
keywords: atherosclerosis; clinical trials; cytokines; inflammation; prevention
references.citation: Am Heart J. 2013 Aug;166(2):199-207.e15
references.pmid: 23895801
references.citation: Circ Res. 2014 Feb 14;114(4):672-6
references.pmid: 24337102
references.citation: Circulation. 2004 Feb 10;109(5):647-55
references.pmid: 14744975
references.citation: Circulation. 2008 May 20;117(20):2577-9
references.pmid: 18490534
references.citation: J Clin Invest. 1988 Feb;81(2):487-98
references.pmid: 3276731
references.citation: Circulation. 2003 Jan 28;107(3):398-404
references.pmid: 12551862
references.citation: Ann Rheum Dis. 2015 Apr;74(4):694-702
references.pmid: 24368514
references.citation: J Am Heart Assoc. 2015 Aug 24;4(8):e002128
references.pmid: 26304941
references.citation: Arthritis Rheum. 2008 Aug;58(8):2443-52
references.pmid: 18668535
references.citation: J Clin Invest. 1996 Feb 1;97(3):769-76
references.pmid: 8609234
references.citation: Eur Heart J. 2014 Jul 14;35(27):1782-91
references.pmid: 24864079
references.citation: J Exp Med. 1984 Aug 1;160(2):618-23
references.pmid: 6332168
references.citation: Semin Cancer Biol. 2012 Feb;22(1):33-40
references.pmid: 22210179
references.citation: J Exp Med. 1947 Apr 30;85(5):491-8
references.pmid: 19871631
references.citation: Circulation. 2006 Jul 25;114(4):281-8
references.pmid: 16847150
references.citation: Circulation. 2013 Oct 22;128(17):1910-23
references.pmid: 24146121
references.citation: N Engl J Med. 1997 Apr 3;336(14):973-9
references.pmid: 9077376
references.citation: Circulation. 2012 Dec 4;126(23):2739-48
references.pmid: 23129601
references.citation: Circulation. 2004 Nov 30;110(22):3493-500
references.pmid: 15557373
references.citation: N Engl J Med. 2006 Aug 10;355(6):581-92
references.pmid: 16899778
references.citation: Nature. 2006 Mar 9;440(7081):237-41
references.pmid: 16407889
references.citation: Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):656-60
references.pmid: 12615675
references.citation: Nat Rev Immunol. 2013 Jan;13(1):34-45
references.pmid: 23222502
references.citation: N Engl J Med. 2008 Oct 30;359(18):1897-908
references.pmid: 18971492
references.citation: Circulation. 1998 Sep 1;98(9):839-44
references.pmid: 9738637
references.citation: Lancet. 1996 May 25;347(9013):1447-51
references.pmid: 8676628
references.citation: JAMA. 2009 Jul 1;302(1):37-48
references.pmid: 19567438
references.citation: Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):272-9
references.pmid: 25538208
references.citation: JAMA. 2001 Nov 7;286(17):2107-13
references.pmid: 11694151
references.citation: Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2394-400
references.pmid: 11073843
references.citation: Am J Cardiol. 2010 May 15;105(10):1371-1377.e1
references.pmid: 20451681
references.citation: Circulation. 2015 Sep 29;132(13):1224-33
references.pmid: 26330412
references.citation: N Engl J Med. 2008 Nov 20;359(21):2195-207
references.pmid: 18997196
references.citation: Diabetes Care. 2007 Apr;30(4):939-45
references.pmid: 17392554
references.citation: J Am Coll Cardiol. 2016 Feb 16;67(6):712-723
references.pmid: 26868696
references.citation: PLoS One. 2010 Jul 23;5(7):e11765
references.pmid: 20668705
references.citation: Nat Rev Cardiol. 2014 May;11(5):255-65
references.pmid: 24663091
references.citation: Lancet Diabetes Endocrinol. 2015 Apr;3(4):228-9
references.pmid: 25726325
references.citation: Circulation. 2000 Apr 18;101(15):1767-72
references.pmid: 10769275
references.citation: Circulation. 2015 Oct 13;132(15):1395-403
references.pmid: 26265659
references.citation: Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1635-40
references.pmid: 15920036
references.citation: Lancet. 2009 Apr 4;373(9670):1175-82
references.pmid: 19329177
references.citation: Am Heart J. 2011 Oct;162(4):597-605
references.pmid: 21982649
references.citation: J Clin Invest. 1985 Nov;76(5):2003-11
references.pmid: 3877078
references.citation: Ann Intern Med. 2015 Feb 17;162(4):266-75
references.pmid: 25686167
references.citation: Circ Res. 2014 Oct 24;115(10):875-83
references.pmid: 25185259
references.citation: N Engl J Med. 1994 Aug 18;331(7):417-24
references.pmid: 7880233
references.citation: Eur Heart J. 2010 Sep;31(17):2092-6
references.pmid: 20675658
references.citation: Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1068-73
references.pmid: 15059807
references.citation: Circulation. 2005 Mar 22;111(11):1355-61
references.pmid: 15753219
references.citation: Eur Heart J. 2015 Feb 7;36(6):377-84
references.pmid: 25079365
references.citation: N Engl J Med. 2009 Jun 4;360(23):2416-25
references.pmid: 19494217
references.citation: Circulation. 2003 Aug 5;108(5):512-5
references.pmid: 12874178
references.citation: J Exp Med. 1941 Jan 31;73(2):183-90
references.pmid: 19871071
references.citation: Rheumatol Int. 2011 Apr;31(4):451-6
references.pmid: 20024554
references.citation: Cardiovasc Res. 1999 Oct;44(1):156-65
references.pmid: 10615399
references.citation: J Thromb Thrombolysis. 2014 May;37(4):475-82
references.pmid: 24242026
references.citation: J Am Heart Assoc. 2014 Jul 10;3(4):
references.pmid: 25012289
references.citation: Circulation. 1998 Feb 10;97(5):425-8
references.pmid: 9490235
references.citation: Nat Med. 2015 Jul;21(7):815-9
references.pmid: 26076037
references.citation: Lancet. 1997 Feb 15;349(9050):462-6
references.pmid: 9040576
references.citation: Atherosclerosis. 2000 Feb;148(2):209-14
references.pmid: 10657556
references.citation: Circulation. 1999 Feb 23;99(7):861-6
references.pmid: 10027806
references.citation: Arthritis Rheum. 2004 Feb;50(2):607-12
references.pmid: 14872505
references.citation: Hypertension. 2005 Nov;46(5):1118-22
references.pmid: 16216991
references.citation: Nature. 2010 Apr 29;464(7293):1357-61
references.pmid: 20428172
references.citation: Circulation. 2012 Apr 10;125(14):1748-56, S1-11
references.pmid: 22399535
references.citation: Circulation. 2003 Oct 7;108(14):1676-8
references.pmid: 14504187
references.citation: Circulation. 2015 Nov 17;132(20):1880-90
references.pmid: 26358260
references.citation: Am J Cardiol. 1990 Jan 15;65(3):168-72
references.pmid: 2296885
references.citation: J Am Coll Cardiol. 2005 Sep 20;46(6):1112-3
references.pmid: 16168299
references.citation: Am J Cardiol. 2013 May 15;111(10):1394-400
references.pmid: 23453459
references.citation: N Engl J Med. 2005 Jan 6;352(1):20-8
references.pmid: 15635109
references.citation: Eur Heart J. 2010 Sep;31(17):2087-91
references.pmid: 20685682
references.citation: Lancet. 2010 Jan 9;375(9709):132-40
references.pmid: 20031199
references.citation: Atherosclerosis. 2013 Jul;229(1):174-81
references.pmid: 23746537
references.citation: Immunity. 2004 Mar;20(3):319-25
references.pmid: 15030775
references.citation: Eur Heart J. 2016 Aug 07;37(30):2406-13
references.pmid: 27161611
references.citation: Circulation. 1999 Feb 2;99(4):546-51
references.pmid: 9927402
references.citation: Blood. 2011 Apr 7;117(14):3720-32
references.pmid: 21304099
references.citation: Lancet Diabetes Endocrinol. 2015 Apr;3(4):243-53
references.pmid: 25726324
references.citation: Circulation. 2013 Aug 6;128(6):632-42
references.pmid: 23838163
references.citation: Nat Rev Drug Discov. 2012 Aug;11(8):633-52
references.pmid: 22850787
references.citation: Nat Rev Immunol. 2011 Feb;11(2):98-107
references.pmid: 21233852
references.citation: Nature. 2011 May 19;473(7347):317-25
references.pmid: 21593864
references.citation: N Engl J Med. 2001 Jun 28;344(26):1959-65
references.pmid: 11430324
references.citation: Clin Chem. 2009 Feb;55(2):209-15
references.pmid: 19095723
references.citation: Circulation. 2000 Oct 31;102(18):2165-8
references.pmid: 11056086
references.citation: Br Heart J. 1982 Mar;47(3):239-43
references.pmid: 7059401
references.citation: Science. 2015 Jul 17;349(6245):316-20
references.pmid: 26185250
references.citation: Lancet. 2012 Mar 31;379(9822):1214-24
references.pmid: 22421340
references.citation: N Engl J Med. 2005 Jan 6;352(1):29-38
references.pmid: 15635110
references.citation: Am J Cardiol. 2007 Jan 1;99(1):99-102
references.pmid: 17196470
references.citation: Lancet. 2004 Nov 13-19;364(9447):1779-85
references.pmid: 15541451
references.citation: Science. 2015 Jul 17;349(6245):237-8
references.pmid: 26185231
references.citation: J Exp Med. 1930 Sep 30;52(4):561-71
references.pmid: 19869788
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8309-14
references.pmid: 15919817
references.citation: Science. 2013 Jan 11;339(6116):161-6
references.pmid: 23307733
references.citation: J Am Coll Cardiol. 2005 May 17;45(10):1644-8
references.pmid: 15893181
references.citation: Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):2032-2040
references.pmid: 23818485
references.citation: Circulation. 1998 May 26;97(20):2007-11
references.pmid: 9610529
references.citation: J Am Coll Cardiol. 2000 Dec;36(7):2168-73
references.pmid: 11127457
references.citation: Eur Heart J. 2015 Feb 7;36(6):337-9
references.pmid: 25205529
references.citation: N Engl J Med. 2000 Mar 23;342(12):836-43
references.pmid: 10733371
references.citation: Lancet. 2012 Mar 31;379(9822):1205-13
references.pmid: 22421339
references.citation: Cancer Metastasis Rev. 2010 Jun;29(2):317-29
references.pmid: 20422276
references.citation: J Am Coll Cardiol. 2013 Jan 29;61(4):404-410
references.pmid: 23265346
references.citation: Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2216-21
references.pmid: 16123325
references.citation: JAMA. 2001 Jul 18;286(3):327-34
references.pmid: 11466099
references.citation: Circulation. 2003 Oct 21;108(16):1930-2
references.pmid: 14530191
references.citation: Eur Heart J. 2014 Mar;35(9):578-89
references.pmid: 24026779